NL7411563A
(nl)
|
1973-09-06 |
1975-03-10 |
Hoechst Ag |
Werkwijze voor het bereiden van synthetisch gemodificeerde trypsine-inhibitoren.
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
GB8430252D0
(en)
|
1984-11-30 |
1985-01-09 |
Beecham Group Plc |
Compounds
|
CA1307736C
(en)
|
1986-03-13 |
1992-09-22 |
David Mark Robertson |
Method of assay of inhibin
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
US4904768A
(en)
|
1987-08-04 |
1990-02-27 |
Bristol-Myers Company |
Epipodophyllotoxin glucoside 4'-phosphate derivatives
|
GB2208511A
(en)
|
1987-08-07 |
1989-04-05 |
Bayer Ag |
Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology
|
US4942184A
(en)
|
1988-03-07 |
1990-07-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water soluble, antineoplastic derivatives of taxol
|
US5632990A
(en)
|
1988-04-22 |
1997-05-27 |
Cancer Research Campaign Tech. Ltd. |
Treatment for tumors comprising conjugated antibody A5B7 and a prodrug
|
US5258499A
(en)
|
1988-05-16 |
1993-11-02 |
Vestar, Inc. |
Liposome targeting using receptor specific ligands
|
US5028697A
(en)
|
1988-08-08 |
1991-07-02 |
Eli Lilly And Company |
Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5948634A
(en)
|
1988-12-21 |
1999-09-07 |
The General Hospital Coporation |
Neural thread protein gene expression and detection of alzheimer's disease
|
DE3912638A1
(de)
|
1989-04-18 |
1990-10-31 |
Bayer Ag |
Gentechnologisch hergestellte homologe des alzheimer protease inhibitors, wirtstaemme sowie expressionsvektoren fuer ihre herstellung und ihre verwendung als arzneimittel
|
US5126249A
(en)
|
1989-05-09 |
1992-06-30 |
Eli Lilly And Company |
Enzymatic removal of a protein amino-terminal sequence
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
US6475781B1
(en)
|
1990-05-17 |
2002-11-05 |
Dana-Farber Cancer Institute, Inc. |
Trans-dominant suppressor genes for oligomeric proteins
|
GB9017008D0
(en)
|
1990-08-02 |
1990-09-19 |
Erba Carlo Spa |
Process for the enzymatic preparation of basic fibroblast growth factor
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
JPH07108232B2
(ja)
|
1990-10-09 |
1995-11-22 |
エム・ディ・リサーチ株式会社 |
ペプチド又は蛋白質の製造方法
|
US6495513B1
(en)
|
1991-03-11 |
2002-12-17 |
Curis, Inc. |
Morphogen-enhanced survival and repair of neural cells
|
CA2101918A1
(en)
|
1991-03-18 |
1992-09-19 |
Samuel Zalipsky |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
US5955444A
(en)
|
1991-08-09 |
1999-09-21 |
Massachusetts Institute Of Technology |
Method of inhibiting abnormal tau hyper phosphorylation in a cell
|
US5908832A
(en)
|
1991-10-07 |
1999-06-01 |
University Of Houston - Clearlake |
Peptide analog
|
US5627270A
(en)
|
1991-12-13 |
1997-05-06 |
Trustees Of Princeton University |
Glycosylated steroid derivatives for transport across biological membranes and process for making and using same
|
US5204354A
(en)
|
1992-02-14 |
1993-04-20 |
Merck & Co., Inc. |
Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
|
GB9213077D0
(en)
|
1992-06-19 |
1992-08-05 |
Erba Carlo Spa |
Polymerbound taxol derivatives
|
JPH08504568A
(ja)
|
1992-09-25 |
1996-05-21 |
コルバス・インターナショナル、インコーポレイテッド |
ウシ膵トリプシン阻害因子から誘導される因子VIIa−組織因子複合体の阻害因子
|
EP0599303A3
(en)
|
1992-11-27 |
1998-07-29 |
Takeda Chemical Industries, Ltd. |
Peptide conjugate
|
EP0675727B1
(en)
|
1992-12-10 |
2002-04-10 |
Enzon, Inc. |
Glycolipid enzyme-polymer conjugates
|
MX9307777A
(es)
|
1992-12-15 |
1994-07-29 |
Upjohn Co |
7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
|
WO1994019692A1
(en)
|
1993-02-18 |
1994-09-01 |
The General Hospital Corporation |
Alzheimer's disease therapeutics
|
US6974578B1
(en)
|
1993-12-28 |
2005-12-13 |
Allergan, Inc. |
Method for treating secretions and glands using botulinum toxin
|
WO1996031531A2
(en)
|
1995-04-04 |
1996-10-10 |
Advanced Bioconcept, Inc. |
Fluorescent peptides
|
JPH11504938A
(ja)
|
1995-05-08 |
1999-05-11 |
サイオス インク. |
クニッツ型プロテアーゼ阻害因子
|
ZA963619B
(en)
|
1995-05-08 |
1996-11-22 |
Scios Inc |
Protease inhibitor peptides
|
AU5908296A
(en)
|
1995-05-31 |
1996-12-24 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for targeted delivery of effector m olecules
|
US5780265A
(en)
|
1995-06-05 |
1998-07-14 |
Genentech, Inc. |
Kunitz type plasma kallikrein inhibitors
|
US5665702A
(en)
|
1995-06-06 |
1997-09-09 |
Biomeasure Incorporated |
Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
|
AU6267896A
(en)
|
1995-06-07 |
1996-12-30 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth oftumors
|
EP0891426B1
(en)
|
1996-03-11 |
2006-05-31 |
Bayer Corporation |
Human bikunin
|
AU2409397A
(en)
|
1996-04-24 |
1997-11-12 |
Rijksuniversiteit Te Groningen |
A prokaryotic protein having functional and structural homology with the uman p-glycoprotein encoded by the mdr-1 gene, nucleic acids encoding and cells expressing said protein
|
CA2252706A1
(en)
|
1996-05-01 |
1997-11-06 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
DE19636889A1
(de)
|
1996-09-11 |
1998-03-12 |
Felix Dr Kratz |
Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
|
US6056973A
(en)
|
1996-10-11 |
2000-05-02 |
Sequus Pharmaceuticals, Inc. |
Therapeutic liposome composition and method of preparation
|
JP2001503396A
(ja)
|
1996-10-11 |
2001-03-13 |
アルザ コーポレイション |
治療用リポソーム組成物および方法
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
JP4116683B2
(ja)
|
1997-02-28 |
2008-07-09 |
ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー |
徐放性局所送達製剤
|
WO1998039469A1
(en)
|
1997-03-04 |
1998-09-11 |
Bio-Technology General Corp. |
Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
|
US6126965A
(en)
|
1997-03-21 |
2000-10-03 |
Georgetown University School Of Medicine |
Liposomes containing oligonucleotides
|
GB9705903D0
(en)
|
1997-03-21 |
1997-05-07 |
Elliott Gillian D |
VP22 Proteins and uses thereof
|
CN1263473A
(zh)
|
1997-05-21 |
2000-08-16 |
利兰·斯坦福青年大学托管委员会 |
增加跨生物膜转运的组合物和方法
|
US6391305B1
(en)
|
1997-09-10 |
2002-05-21 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6093692A
(en)
|
1997-09-25 |
2000-07-25 |
The University Of Southern California |
Method and compositions for lipidization of hydrophilic molecules
|
US6475481B2
(en)
|
1997-11-18 |
2002-11-05 |
Canji Inc |
Purging of stem cell products
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
ATE343595T1
(de)
|
1998-03-12 |
2006-11-15 |
Univ Georgetown |
Peptide enthaltend eine cholesterin- erkennungssequenz und deren verwendungen
|
US5981564A
(en)
|
1998-07-01 |
1999-11-09 |
Universite Laval |
Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
|
GB9814527D0
(en)
|
1998-07-03 |
1998-09-02 |
Cyclacel Ltd |
Delivery system
|
US6703381B1
(en)
|
1998-08-14 |
2004-03-09 |
Nobex Corporation |
Methods for delivery therapeutic compounds across the blood-brain barrier
|
US20040052814A1
(en)
|
1998-09-28 |
2004-03-18 |
Wenyuan Shi |
Fusion proteins for targeted delivery of antimicrobial peptides
|
US5922754A
(en)
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
CA2362937C
(en)
|
1999-02-24 |
2011-03-22 |
The Uab Research Foundation |
Taxane derivatives for targeted therapy of cancer
|
AU754770B2
(en)
|
1999-05-17 |
2002-11-21 |
Conjuchem Biotechnologies Inc. |
Long lasting insulinotropic peptides
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
US6180607B1
(en)
|
1999-08-05 |
2001-01-30 |
Christopher Davies |
Protein having proteinase inhibitor activity
|
US6713454B1
(en)
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
ES2288871T3
(es)
|
1999-09-24 |
2008-02-01 |
Genentech, Inc. |
Derivados de tirosina.
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
DE19953696A1
(de)
|
1999-11-09 |
2001-05-10 |
Alexander Cherkasky |
Selektive proteolytische Synzyme (SPS)
|
GB2360453B
(en)
|
2000-01-05 |
2004-09-01 |
Univ Cardiff |
Treatment of skin conditions
|
US20020041898A1
(en)
|
2000-01-05 |
2002-04-11 |
Unger Evan C. |
Novel targeted delivery systems for bioactive agents
|
US20020086384A1
(en)
|
2000-03-14 |
2002-07-04 |
Zurit Levine |
Splice variants of oncogenes
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
CA2307393A1
(en)
|
2000-05-01 |
2001-11-01 |
The University Of British Columbia |
Ginsenoside chemotherapy
|
AU2001285020A1
(en)
|
2000-08-17 |
2002-02-25 |
Synapse Technologies, Inc. |
P97-active agent conjugates and their methods of use
|
WO2002018434A2
(en)
|
2000-09-01 |
2002-03-07 |
The Governing Council Of The University Of Toronto |
Proteins related to schizophrenia and uses thereof
|
CA2355334A1
(en)
|
2000-10-16 |
2002-04-16 |
Procyon Biopharma Inc. |
Pharmaceutical preparations and methods for inhibiting tumors
|
DE60127571T2
(de)
|
2000-10-20 |
2008-01-24 |
Abbott Laboratories, Abbott Park |
Tiagabine zur behandlung von diabetischer neuropathie
|
JP2004536026A
(ja)
|
2000-11-28 |
2004-12-02 |
トランスフォーム ファーマシューティカルズ,インコーポレーティッド. |
パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
|
EA005584B1
(ru)
|
2000-12-07 |
2005-04-28 |
Эли Лилли Энд Компани |
Слитые белки glp-1
|
US7115565B2
(en)
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
AU2002254400B2
(en)
|
2001-03-23 |
2007-08-09 |
Napro Biotherapeutics, Inc. |
Molecular conjugates for use in treatment of cancer
|
DK1456360T3
(en)
|
2001-04-19 |
2015-08-31 |
Scripps Research Inst |
Methods and Composition for Preparation of Orthogonal TRNA-Aminoacyl-TRNA Synthetase Pairs
|
US20030170891A1
(en)
|
2001-06-06 |
2003-09-11 |
Mcswiggen James A. |
RNA interference mediated inhibition of epidermal growth factor receptor gene expression using short interfering nucleic acid (siNA)
|
WO2003009815A2
(en)
|
2001-07-25 |
2003-02-06 |
Biomarin Pharmaceutical Inc. |
Compositions and methods for modulating blood-brain barrier transport
|
JP2005506340A
(ja)
|
2001-10-16 |
2005-03-03 |
シムバイオンティクス インコーポレイテッド |
血液脳関門をわたる過小グリコシル化タンパク質の標的化のための方法および組成物
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
US7192921B2
(en)
|
2001-11-08 |
2007-03-20 |
The Burnham Institute |
Peptides that home to tumor lymphatic vasculature and methods of using same
|
US20040058865A1
(en)
|
2001-11-26 |
2004-03-25 |
Danishefsky Samuel J |
Homing peptide multimers, their preparation and uses
|
GEP20063806B
(en)
|
2001-12-20 |
2006-04-25 |
Bristol Myers Squibb Co |
Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
|
US20050215478A1
(en)
|
2002-02-07 |
2005-09-29 |
Ben-Sasson Shmuel A |
Amino acid sequences capable of facilitating penetration across a biological barrier
|
JP2005517024A
(ja)
|
2002-02-07 |
2005-06-09 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム |
生物学的障壁を横切る透過を促進し得るアミノ酸配列
|
EP1495045B1
(en)
|
2002-03-29 |
2009-09-02 |
Creagene, Inc. |
Cytoplasmic transduction peptides and uses thereof
|
US6881829B2
(en)
|
2002-04-26 |
2005-04-19 |
Chimeracom, L.L.C. |
Chimeric hybrid analgesics
|
EP1514106A4
(en)
|
2002-05-29 |
2007-05-09 |
Zystor Therapeutics Inc |
TARGETED THERAPEUTIC PROTEINS
|
US20040077540A1
(en)
|
2002-06-28 |
2004-04-22 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
|
EP2305813A3
(en)
|
2002-11-14 |
2012-03-28 |
Dharmacon, Inc. |
Fuctional and hyperfunctional sirna
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
US20040102369A1
(en)
|
2002-11-27 |
2004-05-27 |
The Regents Of The University Of California |
Transport of basic fibroblast growth factor across the blood brain barrier
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
US7319090B2
(en)
|
2002-11-27 |
2008-01-15 |
University Of North Carolina At Chapel Hill |
Methods of treating cerebral ischemia
|
EP1583562B1
(en)
|
2003-01-06 |
2011-06-15 |
Angiochem Inc. |
Angiopep-1, related compounds, and uses thereof
|
US20040162284A1
(en)
|
2003-02-19 |
2004-08-19 |
Harris Herbert W. |
Method of lowering body temperature with (S) tofisopam
|
WO2004091623A1
(en)
|
2003-04-08 |
2004-10-28 |
Progenics Pharmaceuticals. Inc. |
Pharmaceutical formulations containing methylnaltrexone
|
EP1615655B1
(en)
|
2003-04-08 |
2012-02-22 |
Biotempt B.V. |
Use of compositions for mucosal and oral administration comprising hcg fragments
|
DE60336978D1
(de)
|
2003-04-11 |
2011-06-16 |
Pasteur Institut |
Synthetische Peptid-HIV-Vakzine: das CBD-Epitop als effizientes Immunogen zur Induktion HIV-neutralisierender Antikörper
|
EP2664672A1
(en)
|
2003-04-17 |
2013-11-20 |
Alnylam Pharmaceuticals Inc. |
Modified iRNA agents
|
WO2004110498A2
(en)
|
2003-05-14 |
2004-12-23 |
Immunogen, Inc. |
Drug conjugate composition
|
EP1626741A2
(en)
|
2003-05-23 |
2006-02-22 |
Nektar Therapeutics Al, Corporation |
Peg derivatives having an amidocarbonate linkage
|
AU2003286870A1
(en)
|
2003-06-05 |
2005-01-04 |
Salk Institute For Biological Studies |
Targeting polypeptides to the central nervous system
|
AU2004253471B2
(en)
|
2003-06-20 |
2010-05-13 |
Raptor Pharmaceutical Inc. |
Delivery of therapeutic compounds to the brain and other tissues
|
US20050026823A1
(en)
|
2003-06-20 |
2005-02-03 |
Biomarin Pharmaceutical Inc. |
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
|
US7927811B2
(en)
|
2003-08-08 |
2011-04-19 |
Proteus Sciences Co., Ltd. |
Polypeptides having brain-localizing activity and uses thereof
|
US20070275871A1
(en)
|
2003-08-28 |
2007-11-29 |
Biorexis Technology, Inc. |
Epo Mimetic Peptides and Fusion Proteins
|
US20050058702A1
(en)
|
2003-09-17 |
2005-03-17 |
Ben-Sasson Shmuel A. |
Compositions capable of facilitating penetration across a biological barrier
|
US20050208095A1
(en)
|
2003-11-20 |
2005-09-22 |
Angiotech International Ag |
Polymer compositions and methods for their use
|
US7208174B2
(en)
|
2003-12-18 |
2007-04-24 |
Hoffmann-La Roche Inc. |
Liposome compositions
|
EP1768951A4
(en)
|
2004-06-17 |
2011-06-15 |
Musc Found For Res Dev |
NON-NATURAL AMINO ACIDS
|
KR20070039593A
(ko)
|
2004-07-21 |
2007-04-12 |
암브룩스, 인코포레이티드 |
비천연적으로 코딩된 아미노산을 이용한 생합성 폴리펩티드
|
NZ553224A
(en)
|
2004-07-26 |
2009-05-31 |
Asterion Ltd |
Linkers
|
ATE439440T1
(de)
|
2004-09-29 |
2009-08-15 |
Childrens Memorial Hospital |
Sirna-vermitteltes gen-silencing von alpha- synuklein
|
US9002652B1
(en)
|
2005-01-27 |
2015-04-07 |
Institute For Systems Biology |
Methods for identifying and using organ-specific proteins in blood
|
US20090016959A1
(en)
|
2005-02-18 |
2009-01-15 |
Richard Beliveau |
Delivery of antibodies to the central nervous system
|
SI2301531T1
(sl)
|
2005-02-18 |
2018-11-30 |
Abraxis Bioscience, Llc |
Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija
|
EP1877099B1
(en)
|
2005-04-06 |
2012-09-19 |
Genzyme Corporation |
Therapeutic conjugates comprising a lysosomal enzyme, polysialic acid and a targeting moiety
|
EP1888121A2
(en)
|
2005-05-12 |
2008-02-20 |
Tapestry Pharmaceuticals, Inc. |
Anticancer targeted conjugates comprising a succinyl or glutaryl linker
|
US8877714B2
(en)
|
2005-06-14 |
2014-11-04 |
Raptor Pharmaceutical Inc. |
Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereof
|
WO2007009229A1
(en)
|
2005-07-15 |
2007-01-25 |
Angiochem Inc. |
Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
|
KR20080042804A
(ko)
|
2005-07-19 |
2008-05-15 |
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 |
뇌혈관장벽을 통하여 뇌 암세포 내로 침투하는 운반제 및이의 이용 방법
|
GB0517092D0
(en)
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
EP1934359A2
(en)
|
2005-09-08 |
2008-06-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical compositions for delivery of ribonucleic acid to a cell
|
US9062126B2
(en)
|
2005-09-16 |
2015-06-23 |
Raptor Pharmaceuticals Inc. |
Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
|
US8053569B2
(en)
|
2005-10-07 |
2011-11-08 |
Armagen Technologies, Inc. |
Nucleic acids encoding and methods of producing fusion proteins
|
EP2202239A1
(en)
|
2005-11-01 |
2010-06-30 |
Alnylam Pharmaceuticals Inc. |
RNAI inhibition of influenza virus replication
|
US8039432B2
(en)
|
2005-11-09 |
2011-10-18 |
Conjuchem, Llc |
Method of treatment of diabetes and/or obesity with reduced nausea side effect
|
JP2009519945A
(ja)
|
2005-12-16 |
2009-05-21 |
アルゴリン・バイオサイエンス・インコーポレーテツド |
非天然アミノ酸およびそれらのニューロテンシンアナログ
|
US8290433B2
(en)
|
2007-11-14 |
2012-10-16 |
Blaze Mobile, Inc. |
Method and system for securing transactions made through a mobile communication device
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
AU2007223888A1
(en)
|
2006-03-06 |
2007-09-13 |
Amunix, Inc. |
Genetic packages and uses thereof
|
US7477504B1
(en)
|
2006-03-13 |
2009-01-13 |
C.P.D. Technologies, Inc. |
Versatile stun glove
|
BRPI0709246A2
(pt)
|
2006-03-30 |
2011-07-12 |
Glaxo Group Ltd |
anticorpo terapêutico, composição farmacêutica, método de tratamento de um paciente humano acometido com uma doença relacionada com peptìdeo beta-amilóide, uso de um anticorpo terapêutico, e, anticorpo ou fragmento do mesmo
|
EP2089052A4
(en)
|
2006-05-24 |
2011-02-16 |
Peg Biosciences |
POLYETHYLENE GLYCOL-BASED LINK COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES BASED ON SAID COMPOUNDS
|
EP2043696B1
(en)
|
2006-07-13 |
2015-02-25 |
Burnham Institute for Medical Research |
Methods and compositions for targeting gc1qr/p32
|
EP2049144B8
(en)
|
2006-07-21 |
2015-02-18 |
ratiopharm GmbH |
Glycosylation of peptides via o-linked glycosylation sequences
|
EP2046826B1
(en)
|
2006-07-24 |
2011-09-14 |
Biorexis Pharmaceutical Corporation |
Exendin fusion proteins
|
MX2009002893A
(es)
|
2006-09-18 |
2009-07-10 |
Raptor Pharmaceutical Inc |
Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
|
CA2666841A1
(en)
|
2006-10-19 |
2008-04-24 |
Angiochem, Inc. |
Compounds for stimulating p-glycoprotein function and uses thereof
|
WO2008069876A2
(en)
|
2006-10-27 |
2008-06-12 |
University Of Kentucky Research Foundation |
Amidated dopamine neuron stimulating peptides for cns dopaminergic upregulation
|
US9399675B2
(en)
|
2007-02-28 |
2016-07-26 |
The Board Of Regents Of The University Of Oklahoma |
Methods and compositions for diagnosing Alzheimer's disease and age-related macular degeneration
|
CA2681522A1
(en)
|
2007-03-21 |
2008-09-25 |
Raptor Pharmaceutical Inc. |
Cyclic receptor-associated protein (rap) peptides
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
EP2789628A3
(en)
|
2007-05-29 |
2015-03-04 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
WO2009039188A1
(en)
|
2007-09-17 |
2009-03-26 |
Ludwig Institute For Cancer Research Ltd |
Peptides and methods for the treatment of gliomas and other cancers
|
CN104672311A
(zh)
|
2007-10-02 |
2015-06-03 |
玛瑞纳生物技术有限公司 |
用于递送核酸的脂肽
|
WO2009070597A2
(en)
|
2007-11-26 |
2009-06-04 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of gdnf to the cns
|
RU2010129761A
(ru)
|
2007-12-20 |
2012-01-27 |
Ангиочем Инк. (Ca) |
Конъюгаты полипептидов с нуклеиновыми кислотами и их применение
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
ES2951646T3
(es)
|
2008-02-21 |
2023-10-24 |
Burnham Institute For Medical Res |
Métodos y composiciones relacionados con péptidos y proteínas con elementos C-terminales
|
US20110117627A1
(en)
|
2008-07-10 |
2011-05-19 |
The Board Of Trustees Of The University Of Illinois |
Regulation of apoptosis by neural specific splice variants of ig20
|
RU2011118056A
(ru)
|
2008-10-15 |
2012-11-27 |
Ангиокем Инк. |
Конъюгаты агонистов glp-1 и их применение
|
CN102307904A
(zh)
|
2008-12-05 |
2012-01-04 |
安吉奥开米公司 |
神经降压素或神经降压素类似物的缀合物及其用途
|
JP2012510797A
(ja)
|
2008-12-05 |
2012-05-17 |
アンジオケム インコーポレーテッド |
レプチンおよびレプチン類似体コンジュゲートならびにそれらの使用
|
WO2010063124A1
(en)
|
2008-12-05 |
2010-06-10 |
Angiochem Inc. |
Peptide therapeutic conjugates and uses thereof
|
US8853353B2
(en)
|
2008-12-17 |
2014-10-07 |
Angiochem, Inc. |
Membrane type-1 matrix metalloprotein inhibitors and uses thereof
|
WO2010080720A2
(en)
|
2009-01-12 |
2010-07-15 |
Nektar Therapeutics |
Conjugates of a lysosomal enzyme moiety and a water soluble polymer
|
US20100284921A1
(en)
|
2009-05-08 |
2010-11-11 |
Temple University - Of The Commonwealth System Of Higher Education |
Targeted nanoparticles for intracellular cancer therapy
|
US20110111056A1
(en)
|
2009-06-03 |
2011-05-12 |
Dicerna Pharmaceuticals, Inc. |
Peptide dicer substrate agents and methods for their specific inhibition of gene expression
|
MX2011013258A
(es)
|
2009-06-11 |
2012-02-28 |
Angiochem Inc |
Proteinas de fusion para entrega de gdnf y bdnf al sistema nervioso central.
|
EP2448965A4
(en)
|
2009-07-02 |
2015-02-11 |
Angiochem Inc |
MULTIMEPEPTID CONJUGATES AND ITS USES
|
WO2011008823A2
(en)
|
2009-07-14 |
2011-01-20 |
Mayo Foundation For Medical Education And Research |
Peptide-mediated non-covalent delivery of active agents across the blood brain barrier
|
WO2011041897A1
(en)
|
2009-10-06 |
2011-04-14 |
Angiochem Inc. |
Compositions and methods for the transport of therapeutic agents
|
HUE044865T2
(hu)
|
2009-10-09 |
2019-11-28 |
Armagen Inc |
Eljárások és készítmények a központi idegrendszerben iduronát-2-szulfatáz-aktivitás növelésére
|
EP3670539A1
(en)
|
2009-11-13 |
2020-06-24 |
Daiichi Sankyo Europe GmbH |
Material and methods for treating or preventing her-3 associated diseases
|
US8530429B2
(en)
|
2009-11-24 |
2013-09-10 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
US9095541B2
(en)
|
2009-11-24 |
2015-08-04 |
Arch Cancer Therapeutics, Inc. |
Brain tumor targeting peptides and methods
|
EP2333074A1
(en)
|
2009-12-14 |
2011-06-15 |
Robert Steinfeld |
Substances and methods for the treatment of lysosmal storage diseases
|
US9180105B2
(en)
|
2010-03-08 |
2015-11-10 |
Sloan-Kettering Institute For Cancer Research |
CDC7 kinase inhibitors and uses thereof
|
EP2550285B1
(en)
|
2010-03-22 |
2017-07-19 |
President and Fellows of Harvard College |
Trioxacarcins and uses thereof
|
WO2011119608A1
(en)
|
2010-03-26 |
2011-09-29 |
University Of Tennessee Research Foundation |
Peptides that specifically target amyloid deposits
|
CA2796215C
(en)
|
2010-04-14 |
2021-05-18 |
National Research Council Of Canada |
Compositions and methods for brain delivery of analgesic peptides
|
CN103002891B
(zh)
|
2010-05-10 |
2016-10-26 |
加利福尼亚大学董事会 |
比例计量型组合药物递送
|
WO2011153642A1
(en)
|
2010-06-10 |
2011-12-15 |
Angiochem Inc. |
Leptin and leptin analog conjugates and fusion proteins and uses thereof
|
MX2013000250A
(es)
|
2010-07-02 |
2013-10-28 |
Angiochem Inc |
Polipeptidos cortos y que contienen d-aminoacido para conjugados terapeuticos y usos de los mismos.
|
US8218280B2
(en)
|
2010-07-08 |
2012-07-10 |
Schneider Electric USA, Inc. |
Secondary thermal sensor for primary conductors
|
EP2601220A2
(en)
|
2010-08-06 |
2013-06-12 |
U3 Pharma GmbH |
Use of her3 binding agents in prostate treatment
|
CN102406949B
(zh)
|
2010-09-21 |
2013-05-29 |
复旦大学 |
一种靶向示踪的多模式诊断纳米影像药物
|
WO2012037687A1
(en)
|
2010-09-23 |
2012-03-29 |
Angiochem Inc. |
Therapeutic polypeptides and uses thereof
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
複素環化合物及びその使用
|
CN103561726A
(zh)
|
2010-11-18 |
2014-02-05 |
通用医疗公司 |
用于癌症治疗的抗高血压剂的新型组合物和用途
|
CN102552928A
(zh)
|
2010-12-19 |
2012-07-11 |
复旦大学 |
一种治疗脑部肿瘤的双级靶向递药系统及其制备方法
|
SG10201600179RA
(en)
|
2011-01-10 |
2016-02-26 |
Infinity Pharmaceuticals Inc |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
CN102614105A
(zh)
|
2011-01-28 |
2012-08-01 |
复旦大学 |
一种脑靶向载两性霉素b聚合物胶束给药系统
|
CN103501766B
(zh)
|
2011-03-01 |
2016-08-17 |
to-BBB控股股份有限公司 |
不良水溶性物质的高主动脂质体装载
|
EP2691443B1
(en)
|
2011-03-28 |
2021-02-17 |
Massachusetts Institute of Technology |
Conjugated lipomers and uses thereof
|
EP2696898A4
(en)
|
2011-04-07 |
2014-10-01 |
Univ Emory |
COMPOSITIONS COMPRISING SACCHARIDE BINDING FRACTIONS AND METHODS FOR TARGETED THERAPY
|
AR085958A1
(es)
|
2011-04-08 |
2013-11-06 |
Afraxis Inc |
8-etil-6-(aril)pirido[2,3-d]pirimidin-7(8h)-onas para el tratamiento de trastornos del cns y cancer
|
US9700579B2
(en)
|
2011-04-27 |
2017-07-11 |
Yale University |
Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits
|
US20140213641A1
(en)
|
2011-05-09 |
2014-07-31 |
Institut Quimic De Sarria |
Polymeric nanoparticles for drug delivery
|
WO2013004716A1
(en)
|
2011-07-04 |
2013-01-10 |
Universität Basel |
Peptide beads
|
AU2012284091B2
(en)
|
2011-07-19 |
2015-11-12 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
US8969363B2
(en)
|
2011-07-19 |
2015-03-03 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
EP2741749A4
(en)
|
2011-08-11 |
2015-04-15 |
Intellikine Llc |
KINASE-INHIBITING POLYMORPH
|
CA2846431A1
(en)
|
2011-08-29 |
2013-03-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
WO2013056096A1
(en)
|
2011-10-13 |
2013-04-18 |
Angiochem Inc. |
Polypeptide-opioid conjugates and uses thereof
|
CN113149869A
(zh)
|
2011-10-27 |
2021-07-23 |
麻省理工学院 |
能够形成药物包封微球的在n末端上官能化的氨基酸衍生物
|
JP6078076B2
(ja)
|
2011-11-11 |
2017-02-08 |
インテリカイン, エルエルシー |
キナーゼ阻害剤多形体
|
RU2014126484A
(ru)
|
2011-12-01 |
2016-02-10 |
Ангиочем Инк. |
Нацеленные соединения лизосомальных ферментов
|
CA2857548A1
(en)
|
2011-12-01 |
2013-06-06 |
Angiochem Inc. |
Targeted enzyme compounds and uses thereof
|
LT2790668T
(lt)
|
2011-12-13 |
2020-12-28 |
Engeneic Molecular Delivery Pty Ltd. |
Iš bakterijų gautos, nepažeistos miniląstelės, skirtos terapinių agentų pristatymui į smegenų navikus
|
EP2791210A1
(en)
|
2011-12-16 |
2014-10-22 |
Massachusetts Institute of Technology |
Alpha-aminoamidine polymers and uses thereof
|
WO2013120107A1
(en)
|
2012-02-09 |
2013-08-15 |
University Of Rochester |
Methods and compositions for treating a subject to inhibit hearing loss
|
EP3153523A3
(en)
|
2012-03-02 |
2017-05-03 |
Icahn School of Medicine at Mount Sinai |
Variants of prothymosin alpha and methods of using same
|
AU2013243873B2
(en)
|
2012-04-04 |
2016-08-25 |
Halozyme, Inc. |
Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
|
WO2013162757A1
(en)
|
2012-04-26 |
2013-10-31 |
Yale University |
Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use
|
BR112014031273A2
(pt)
|
2012-06-15 |
2017-07-25 |
Angiochem Inc |
compostos enzima alvejados e seus usos
|
EP2882706A1
(en)
|
2012-08-13 |
2015-06-17 |
Massachusetts Institute of Technology |
Amine-containing lipidoids and uses thereof
|
WO2014026286A1
(en)
|
2012-08-14 |
2014-02-20 |
Angiochem Inc. |
Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin
|
US9687561B2
(en)
|
2012-08-14 |
2017-06-27 |
Angiochem Inc. |
Peptide-dendrimer conjugates and uses thereof
|
PE20150646A1
(es)
|
2012-08-16 |
2015-05-21 |
Ipierian Inc |
Metodos de tratamiento de una tauopatia
|
JP6584952B2
(ja)
|
2012-11-01 |
2019-10-02 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Pi3キナーゼアイソフォームモジュレーターを用いる癌の治療
|
US20140120083A1
(en)
|
2012-11-01 |
2014-05-01 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
CN104884088B
(zh)
|
2012-11-02 |
2018-06-15 |
美国比奥维拉迪维股份有限公司 |
抗补体C1s抗体和其用途
|
EP2917244B1
(en)
|
2012-11-12 |
2021-01-06 |
Angiochem Inc. |
Aprotinin-derived polypeptide-antibody conjugates
|
GB201220474D0
(en)
|
2012-11-14 |
2012-12-26 |
Sagetis Biotech Sl |
Polypeptides
|
EP2922575B1
(en)
|
2012-11-26 |
2019-06-26 |
President and Fellows of Harvard College |
Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof
|
WO2014082163A1
(en)
|
2012-11-28 |
2014-06-05 |
Zhou Youwen |
Tox inhibition for the treatment of cancer
|
CN104955946A
(zh)
|
2012-11-30 |
2015-09-30 |
安吉奥开米公司 |
靶向的艾杜糖醛酸-2-硫酸酯酶化合物
|
HK1179821A2
(en)
|
2013-05-28 |
2013-10-04 |
Chit Shun Catv Equipment Ltd |
High voltage discharge protection device and radio frequency transmission apparatus using the same
|
WO2014194428A1
(en)
|
2013-06-06 |
2014-12-11 |
Angiochem Inc. |
Targeted heparan sulfatase compounds
|
US20160367691A1
(en)
|
2013-06-06 |
2016-12-22 |
Angiochem Inc. |
Targeted enzyme compounds and uses thereof
|